# EDGAR Filing Document

**Accession Number:** 0001604877
**File Stem:** 0000899243-23-003742
**Filing Date:** 2023-2
**Character Count:** 8230
**Document Hash:** dbe3202743fd7ae2ee9d576da3a12fb0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899243-23-003742.hdr.sgml**: 20230202

**ACCESSION NUMBER**: 0000899243-23-003742

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230202

**DATE AS OF CHANGE**: 20230202

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Hallsworth Frederick
- **CENTRAL INDEX KEY:** 0001604877

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36415
- **FILM NUMBER:** 23583380

**MAIL ADDRESS:**
- **STREET 1:** THE GARDEN WING, HOUSTON HOUSE
- **STREET 2:** KIRK ROAD
- **CITY:** HOUSTON
- **STATE:** X0
- **ZIP:** PA6 7AR
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Quotient Ltd
- **CENTRAL INDEX KEY:** 0001596946
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 264719797
- **STATE OF INCORPORATION:** Y9
- **FISCAL YEAR END:** 0331

**BUSINESS ADDRESS:**
- **STREET 1:** 28 ESPLANADE
- **CITY:** SAINT HELIER
- **STATE:** Y9
- **ZIP:** JE2 3QA
- **BUSINESS PHONE:** 41274832286

**MAIL ADDRESS:**
- **STREET 1:** 28 ESPLANADE
- **CITY:** SAINT HELIER
- **STATE:** Y9
- **ZIP:** JE2 3QA

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Hallsworth Frederick<br><sub>(Last) (First) (Middle)</sub><br>28 ESPLANADE<br><sub>(Street)</sub><br>ST HELIER, Y9 JE2 3QA<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-31 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Quotient Ltd [ QTNT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 2023-01-31 |  | M |  | 438 | A | <sup>(1)</sup> | 6186 | D |  |
| Ordinary Shares |  |  |  |  |  |  |  | 78 | I | By wife |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Ordinary Shares Option (Right to buy) | $464.80 |  |  |  |  |  |  | <sup>(2)</sup> | 2025-10-31 | Ordinary Shares | 187 |  | 187 | D |  |
| Ordinary Shares Option (Right to Buy) | $320.00 |  |  |  |  |  |  | <sup>(3)</sup> | 2024-04-29 | Ordinary Shares | 125 |  | 125 | D |  |
| Ordinary Shares Option (Right to Buy) | <sup>(4)</sup> |  |  |  |  |  |  | <sup>(5)</sup> | 2022-08-30 | Ordinary Shares | 500 |  | 500 | D |  |
| Ordinary Shares Option (Right to Buy) | $398.00 |  |  |  |  |  |  | <sup>(6)</sup> | 2024-10-31 | Ordinary Shares | 125 |  | 125 | D |  |
| Ordinary Shares Option (Right to Buy) | $229.20 |  |  |  |  |  |  | <sup>(7)</sup> | 2026-10-31 | Ordinary Shares | 218 |  | 218 | D |  |
| Ordinary Shares Option (Right to Buy) | $208.40 |  |  |  |  |  |  | <sup>(8)</sup> | 2027-10-31 | Ordinary Shares | 239 |  | 239 | D |  |
| Ordinary Shares Option (Right to Buy) | $256.40 |  |  |  |  |  |  | <sup>(9)</sup> | 2028-10-31 | Ordinary Shares | 156 |  | 156 | D |  |
| Ordinary Shares Option (Right to Buy) | $311.20 |  |  |  |  |  |  | <sup>(10)</sup> | 2029-10-31 | Ordinary Shares | 203 |  | 203 | D |  |
| Ordinary Shares Option (Right to Buy) | $182.00 |  |  |  |  |  |  | <sup>(11)</sup> | 2030-10-31 | Ordinary Shares | 340 |  | 340 | D |  |
| Ordinary Shares Option (Right to Buy) | $101.20 |  |  |  |  |  |  | <sup>(12)</sup> | 2031-10-31 | Ordinary Shares | 601 |  | 601 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-01-31 |  | M |  |  | 438 | <sup>(13)</sup> | <sup>(13)</sup> | Ordinary Shares | 438 | $0.00 | 1312 | D |  |
| Ordinary Shares Option (Right to Buy) | $5.20 |  |  |  |  |  |  | <sup>(14)</sup> | 2032-10-31 | Ordinary Shares | 1000 |  | 1000 | D |  |

---

### Footnotes:

(1) Restricted Stock Units convert into ordinary shares on a one-for-one basis.

(2) All 187 options have vested and remain exercisable.

(3) All 125 options have vested and remain exercisable.

(4) The exercise price will be paid in pounds sterling, at GBP36.40 per share.

(5) All 500 options have vested and remain exercisable.

(6) All 125 options have vested and remain exercisable.

(7) All 218 options have vested and remain exercisable.

(8) All 239 options have vested and remain exercisable.

(9) All 156 options have vested and remain exercisable.

(10) All 203 options have vested and remain exercisable.

(11) All 340 options have vested and remain exercisable.

(12) All 601 options have vested and remain exercisable.

(13) On October 31, 2022, the Reporting Person was granted 1,750 restricted stock units, of which 438 have vested and have converted into ordinary shares. The remaining 1,312 restricted stock units will vest in three equal installments on April 30, 2023, July 31, 2023 and October 31, 2023.

(14) The options vest and become exercisable on October 31, 2023.

**Signature:** /s/ Frederick Hallsworth  
**Date:** 2023-02-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**